Clinical Decision Support Tools for Optimizing Guideline-Directed Medical Therapy for Heart Failure: Computing the Possibilities
- PMID: 38939604
- PMCID: PMC11198467
- DOI: 10.1016/j.jacadv.2023.100354
Clinical Decision Support Tools for Optimizing Guideline-Directed Medical Therapy for Heart Failure: Computing the Possibilities
Keywords: clinical decision support; health technology; heart failure; medications.
Conflict of interest statement
The author has reported that he has no relationships relevant to the contents of this paper to disclose.
Comment on
- doi: 10.1016/j.jacadv.2023.100289
References
-
- Fonarow G.C., Hernandez A.F., Solomon S.D., Yancy C.W. Potential mortality reduction with optimal implementation of angiotensin receptor neprilysin inhibitor therapy in heart failure. JAMA Cardiol. 2016;1:714–717. - PubMed
-
- Heidenreich P.A., Bozkurt B., Aguilar D., et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(17):e263–e421. - PubMed
-
- Tromp J., Ouwerkerk W., van Veldhuisen D.J., et al. A systematic review and network meta-analysis of pharmacological treatment of heart failure with reduced ejection fraction. J Am Coll Cardiol HF. 2022;10:73–84. - PubMed
-
- Greene S.J., Butler J., Hellkamp A.S., et al. Comparative effectiveness of dosing of medical therapy for heart failure: from the CHAMP-HF registry. J Card Fail. 2022;28:370–384. - PubMed
-
- Greene S.J., Butler J., Albert N.M., et al. Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry. J Am Coll Cardiol. 2018;72:351–366. - PubMed
Publication types
LinkOut - more resources
Full Text Sources